President and CEO of Daiichi Sankyo
Our five corporate units, Corporate Strategy, Corporate Planning & Management, Digital Transformation Management, Business Development, and Corporate Affairs support, our CEO in developing comprehensive and consistent corporate strategies and ensuring smooth management of the Daiichi Sankyo Group.
Head of Corporate Strategy Unit
Head of Corporate Planning & Management Unit (Chief Financial Officer)
Head of Digital Transformation Management Unit, CIO
Head of Business Development Unit
Head of Corporate Affairs Unit, CISO
CISO: Chief Information Security Officer
CIO: Chief Information Officer
Our six functional units, Research & Development, Biologics, Pharmaceutical Technology, Supply Chain, Quality Assurance & Regulatory Affairs, and Clinical Safety & Pharmacovigilance, help formulate and execute global strategies in their specialties. Each unit determines areas to be expanded globally, guides strategic planning and execution, and improves the efficiency of business operations.
Head of Research & Development Unit
Head of Biologics Unit
Head of Pharmaceutical Technology Unit
Head of Supply Chain Unit
Head of Quality Assurance & Regulatory Affairs Unit
Head of Clinical Safety & Pharmacovigilance Unit
Our six business units are responsible for strategic planning and execution in the regions of our business operations.
Head of Japan Business Unit
Head of Oncology Business Unit
President & CEO, Daiichi Sankyo, Inc.
Jan Van Ruymbeke
Head of EU Specialty Business Unit
Managing Director, Daiichi Sankyo Europe GmbH
Head of ASCA Business Unit
President, ASCA Company
Head of American Regent Unit
President & CEO, American Regent, Inc.
Head of Daiichi Sankyo Healthcare Unit
Representative Director, President
Daiichi Sankyo Healthcare Co., Ltd.
General Counsel provides legal advice to the CEO.
Head of Legal Affairs Department